Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer
- PMID: 24410859
- DOI: 10.1111/codi.12552
Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer
Abstract
Aim: The purpose of the study was to develop a tool for predicting the individual risk of metachronous peritoneal carcinomatosis after surgery for non-metastatic colorectal cancer.
Method: Independent predictors for metachronous colorectal carcinomatosis have previously been identified using a population-based database. Predictive models for colon and rectal cancer were developed from these data. The predictive models were based on multivariable Cox proportional hazard regression and were internally validated with bootstrapping. Performance was assessed by the concordance index and calibration plots.
Results: In all, 8044 patients who underwent abdominal resection of colorectal cancer Stage I-III were included. The colon and rectal cancer risk score models predicted metachronous peritoneal carcinomatosis with a concordance index of 80% and 78%, respectively. Factors in the models included age, pathological pT stage, pN stage, number of examined lymph nodes (0-11, 12+), type of surgery (emergency/elective), completeness of cancer resection (R0/R1/R2), adjuvant chemotherapy (yes/no), preoperative radiotherapy and tumour location.
Conclusion: The proposed predictive models showed high internal validity and enabled individualized prediction of peritoneal recurrence of colorectal cancer. The models may help in the planning of treatment and follow-up of patients. However, external validation is warranted to assess generalizability of the predicted absolute risks.
Keywords: Colorectal cancer; individual risk; peritoneal carcinomatosis.
Colorectal Disease © 2014 The Association of Coloproctology of Great Britain and Ireland.
Comment in
-
Improving timely detection and recording of colorectal peritoneal metastases.Colorectal Dis. 2014 Dec;16(12):1019-20. doi: 10.1111/codi.12794. Colorectal Dis. 2014. PMID: 25283313 No abstract available.
Similar articles
-
External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer.Colorectal Dis. 2016 Apr;18(4):378-85. doi: 10.1111/codi.13219. Colorectal Dis. 2016. PMID: 26588669
-
A novel data-driven prognostic model for staging of colorectal cancer.J Am Coll Surg. 2011 Nov;213(5):579-588, 588.e1-2. doi: 10.1016/j.jamcollsurg.2011.08.006. Epub 2011 Sep 16. J Am Coll Surg. 2011. PMID: 21925905
-
Risk factors for appendiceal and colorectal peritoneal metastases.Eur J Surg Oncol. 2018 Jul;44(7):997-1005. doi: 10.1016/j.ejso.2018.02.245. Epub 2018 Mar 6. Eur J Surg Oncol. 2018. PMID: 29576463
-
Colorectal cancer and peritoneal carcinomatosis.Semin Surg Oncol. 1996 Jul-Aug;12(4):267-78. doi: 10.1002/(SICI)1098-2388(199607/08)12:4<267::AID-SSU6>3.0.CO;2-3. Semin Surg Oncol. 1996. PMID: 8829286 Review.
-
[Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal colorectal carcinomatosis: a newly validated standard whose contribution remains to be assessed].Bull Cancer. 2005 Feb;92(2):151-4. Bull Cancer. 2005. PMID: 15749644 Review. French.
Cited by
-
Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options.Curr Treat Options Oncol. 2018 Sep 1;19(10):49. doi: 10.1007/s11864-018-0563-8. Curr Treat Options Oncol. 2018. PMID: 30173342 Review.
-
Novel Nomograms Individually Predicting Overall Survival of Non-metastatic Colon Cancer Patients.Front Oncol. 2020 May 6;10:733. doi: 10.3389/fonc.2020.00733. eCollection 2020. Front Oncol. 2020. PMID: 32435623 Free PMC article.
-
Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research.J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S206-S213. doi: 10.21037/jgo-20-133. J Gastrointest Oncol. 2021. PMID: 33968438 Free PMC article. Review.
-
CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells.Clin Exp Metastasis. 2021 Aug;38(4):401-410. doi: 10.1007/s10585-021-10103-0. Epub 2021 Jun 11. Clin Exp Metastasis. 2021. PMID: 34115261 Free PMC article.
-
Cytoreductive surgery without intra-peritoneal chemotherapy for metachronous colorectal peritoneal metastases.World J Surg Oncol. 2024 Jul 31;22(1):205. doi: 10.1186/s12957-024-03471-w. World J Surg Oncol. 2024. PMID: 39085860 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical